Unknown

Dataset Information

0

Tumor-infiltrating Leukocyte Profiling Defines Three Immune Subtypes of NSCLC with Distinct Signaling Pathways and Genetic Alterations.


ABSTRACT: Resistance to immune checkpoint blockade remains challenging in patients with non-small cell lung cancer (NSCLC). Tumor-infiltrating leukocyte (TIL) quantity, composition, and activation status profoundly influence responsiveness to cancer immunotherapy. This study examined the immune landscape in the NSCLC tumor microenvironment by analyzing TIL profiles of 281 fresh resected NSCLC tissues. Unsupervised clustering based on numbers and percentages of 30 TIL types classified adenocarcinoma (LUAD) and squamous cell carcinoma (LUSQ) into the cold, myeloid cell-dominant, and CD8+ T cell-dominant subtypes. These were significantly correlated with patient prognosis; the myeloid cell subtype had worse outcomes than the others. Integrated genomic and transcriptomic analyses, including RNA sequencing, whole-exome sequencing, T-cell receptor repertoire, and metabolomics of tumor tissue, revealed that immune reaction-related signaling pathways were inactivated, while the glycolysis and K-ras signaling pathways activated in LUAD and LUSQ myeloid cell subtypes. Cases with ALK and ROS1 fusion genes were enriched in the LUAD myeloid subtype, and the frequency of TERT copy-number variations was higher in LUSQ myeloid subtype than in the others. These classifications of NSCLC based on TIL status may be useful for developing personalized immune therapies for NSCLC.

Significance

The precise TIL profiling classified NSCLC into novel three immune subtypes that correlates with patient outcome, identifying subtype-specific molecular pathways and genomic alterations that should play important roles in constructing subtype-specific immune tumor microenvironments. These classifications of NSCLC based on TIL status are useful for developing personalized immune therapies for NSCLC.

SUBMITTER: Aoki K 

PROVIDER: S-EPMC10263066 | biostudies-literature | 2023 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Tumor-infiltrating Leukocyte Profiling Defines Three Immune Subtypes of NSCLC with Distinct Signaling Pathways and Genetic Alterations.

Aoki Kazunori K   Nishito Yukari Y   Motoi Noriko N   Arai Yasuhito Y   Hiraoka Nobuyoshi N   Shibata Tatsuhiro T   Sonobe Yukiko Y   Kayukawa Yoko Y   Hashimoto Eri E   Takahashi Mina M   Fujii Etsuko E   Nishizawa Takashi T   Fukuda Hironori H   Ohashi Kana K   Arai Kosuke K   Mizoguchi Yukihiro Y   Yoshida Yukihiro Y   Watanabe Shun-Ichi SI   Yamashita Makiko M   Kitano Shigehisa S   Sakamoto Hiromi H   Nagata Yuki Y   Mitsumori Risa R   Ozaki Kouichi K   Niida Shumpei S   Kanai Yae Y   Hirayama Akiyoshi A   Soga Tomoyoshi T   Maruyama Toru T   Tsukada Keisuke K   Yabuki Nami N   Shimada Mei M   Kitazawa Takehisa T   Natori Osamu O   Sawada Noriaki N   Kato Atsuhiko A   Yoshida Teruhiko T   Yasuda Kazuki K   Mizuno Hideaki H   Tsunoda Hiroyuki H   Ochiai Atsushi A  

Cancer research communications 20230613 6


Resistance to immune checkpoint blockade remains challenging in patients with non-small cell lung cancer (NSCLC). Tumor-infiltrating leukocyte (TIL) quantity, composition, and activation status profoundly influence responsiveness to cancer immunotherapy. This study examined the immune landscape in the NSCLC tumor microenvironment by analyzing TIL profiles of 281 fresh resected NSCLC tissues. Unsupervised clustering based on numbers and percentages of 30 TIL types classified adenocarcinoma (LUAD)  ...[more]

Similar Datasets

| S-EPMC11892499 | biostudies-literature
2024-08-19 | GSE271517 | GEO
| S-EPMC9648410 | biostudies-literature
| S-EPMC8292364 | biostudies-literature
| S-EPMC6311038 | biostudies-literature
| PRJNA1132152 | ENA
| S-EPMC6712670 | biostudies-literature
| S-EPMC8065300 | biostudies-literature
| S-EPMC11310866 | biostudies-literature
| S-EPMC9763853 | biostudies-literature